Literature DB >> 6345522

Fatty acyl derivatives of glucosamine 1-phosphate in Escherichia coli and their relation to lipid A. Complete structure of A diacyl GlcN-1-P found in a phosphatidylglycerol-deficient mutant.

K Takayama, N Qureshi, P Mascagni, M A Nashed, L Anderson, C R Raetz.   

Abstract

We have determined the complete structure of a glycolipid (designated lipid X) previously found to accumulate in certain Escherichia coli mutants defective in phosphatidylglycerol synthesis (Nishijima, M., and Raetz, C.R.H. (1979) J. Biol. Chem. 254, 7837-7844). Based on fast atom bombardment mass spectrometry and proton nuclear magnetic resonance studies, this substance is an acylated metabolite of glucosamine 1-phosphate. Lipid X of E. coli has a Mr = 711.87 as the free acid (C34H66NO12P) and contains two beta-hydroxymyristate moieties, one attached as an amide at the 2 position and the other as an ester at the 3 position of the sugar. It has free hydroxyl groups at the 4 and 6 positions, and the anomeric configuration is alpha. The structure of lipid X from E. coli closely resembles the reducing end subunit of lipid A, and it might represent a very early precursor in the biosynthesis of lipid A. To our knowledge, fatty acyl derivatives of glucosamine 1-phosphate have not been reported previously.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345522

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Nucleotide sequence of the Escherichia coli gene for lipid A disaccharide synthase.

Authors:  D N Crowell; W S Reznikoff; C R Raetz
Journal:  J Bacteriol       Date:  1987-12       Impact factor: 3.490

2.  Immunostimulatory, but not antiendotoxin, activity of lipid X is due to small amounts of contaminating N,O-acylated disaccharide-1-phosphate: in vitro and in vivo reevaluation of the biological activity of synthetic lipid X.

Authors:  C Lam; J Hildebrandt; E Schütze; B Rosenwirth; R A Proctor; E Liehl; P Stütz
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

Review 3.  The lipid network.

Authors:  Marc-Antoine Sani; Frances Separovic; John D Gehman
Journal:  Biophys Rev       Date:  2012-03-24

4.  Activation and inhibition of Limulus amebocyte lysate coagulation by chemically defined substructures of lipid A.

Authors:  R A Proctor; J A Textor
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

5.  Monoclonal antibodies specific for Escherichia coli J5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species.

Authors:  L M Mutharia; G Crockford; W C Bogard; R E Hancock
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

6.  Molecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharides.

Authors:  P J Baker; T Hraba; C E Taylor; P W Stashak; M B Fauntleroy; U Zähringer; K Takayama; T R Sievert; X Hronowski; R J Cotter
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  Inhibition of endotoxin-induced priming of human neutrophils by lipid X and 3-Aza-lipid X.

Authors:  R L Danner; K A Joiner; J E Parrillo
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

8.  Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi.

Authors:  K Takayama; R J Rothenberg; A G Barbour
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

9.  An outer membrane enzyme that generates the 2-amino-2-deoxy-gluconate moiety of Rhizobium leguminosarum lipid A.

Authors:  Nanette L S Que-Gewirth; Shanhua Lin; Robert J Cotter; Christian R H Raetz
Journal:  J Biol Chem       Date:  2003-01-15       Impact factor: 5.157

10.  Influence of fine structure of lipid A on Limulus amebocyte lysate clotting and toxic activities.

Authors:  K Takayama; N Qureshi; C R Raetz; E Ribi; J Peterson; J L Cantrell; F C Pearson; J Wiggins; A G Johnson
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.